• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

**标题**:**Kratom**(**代**孕**草**)**有**作**为抗抑**郁**和抗精**神**病**药物的潜**力**。

The Potential for Kratom as an Antidepressant and Antipsychotic.

机构信息

College of Pharmacy, Department of Medicinal Chemistry, University of Florida, Gainesville, FL.

Midwestern University, College of Pharmacy, Department of Pharmaceutical Sciences, Glendale, AZ.

出版信息

Yale J Biol Med. 2020 Jun 29;93(2):283-289. eCollection 2020 Jun.

PMID:32607089
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7309668/
Abstract

, otherwise known as kratom, is a plant in the coffee family (Rubiaceae) native to Southeast Asia and Thailand whose leaves have been shown to cause opioid-like and stimulant responses upon ingestion. The major pharmacologically active compounds present in kratom, mitragynine and 7-hydroxymitragynine (7-HMG), are both indole alkaloids and are responsible for its opioid-like activity. While kratom is most commonly known for its affinity for mu-opioid receptors, research has shown one of its active components has effects on the same receptors to which some antipsychotics bind, such as D dopamine, serotonin (5-HT and 5-HT), and alpha-2 adrenergic receptors displaying possible indications of kratom to be used as both antipsychotics and antidepressants. Although studies to evaluate this effect are still lacking, several online and in-person surveys note relief of depression and anxiety symptoms among those who consume kratom products, and in fact identify it as a common reason for consumption. This then highlights the dire need for further research to be conducted on kratom, its mechanism of action and the constituents that elicit these antidepressant, anxiolytic, and antipsychotic properties.

摘要

,也被称为,是一种原产于东南亚和泰国的咖啡科(Rubiaceae)植物,其叶子被证明在摄入后会引起类阿片和兴奋剂反应。存在于中的主要药理活性化合物,,和 7-羟基美沙酮(7-HMG),都是吲哚生物碱,是其类阿片活性的原因。虽然最常被称为其对μ-阿片受体的亲和力,但研究表明其一种活性成分对一些抗精神病药结合的相同受体有影响,如多巴胺 D、血清素(5-HT 和 5-HT)和α-2 肾上腺素能受体,显示出作为抗精神病药和抗抑郁药使用的可能性。尽管评估这种效果的研究仍然缺乏,但一些在线和现场调查注意到那些消费产品的人抑郁和焦虑症状的缓解,实际上将其确定为消费的常见原因。这就凸显了对进一步研究的迫切需要,包括对其作用机制和引起这些抗抑郁、抗焦虑和抗精神病特性的成分进行研究。

相似文献

1
The Potential for Kratom as an Antidepressant and Antipsychotic.**标题**:**Kratom**(**代**孕**草**)**有**作**为抗抑**郁**和抗精**神**病**药物的潜**力**。
Yale J Biol Med. 2020 Jun 29;93(2):283-289. eCollection 2020 Jun.
2
Abuse liability and therapeutic potential of the Mitragyna speciosa (kratom) alkaloids mitragynine and 7-hydroxymitragynine.滥用倾向和治疗潜力的Mitragyna speciosa(Kratom)生物碱:mitragynine 和 7-hydroxymitragynine。
Addict Biol. 2019 Sep;24(5):874-885. doi: 10.1111/adb.12639. Epub 2018 Jun 27.
3
The medicinal chemistry and neuropharmacology of kratom: A preliminary discussion of a promising medicinal plant and analysis of its potential for abuse.**关键词**:药用化学;神经药理学;咔哇;初步讨论;药用植物;滥用潜力 咔哇的药用化学和神经药理学:一种有前途的药用植物的初步讨论及其滥用潜力的分析。
Neuropharmacology. 2018 May 15;134(Pt A):108-120. doi: 10.1016/j.neuropharm.2017.08.026. Epub 2017 Aug 19.
4
Chemical composition and biological effects of kratom (Mitragyna speciosa): In vitro studies with implications for efficacy and drug interactions.植物化学成分与生物效应:东革阿里(蒺藜科植物)的体外研究与疗效和药物相互作用的关系。
Sci Rep. 2020 Nov 5;10(1):19158. doi: 10.1038/s41598-020-76119-w.
5
Suspected Adulteration of Commercial Kratom Products with 7-Hydroxymitragynine.怀疑商业 kratom 产品掺假含有 7-羟基帽柱木碱。
J Med Toxicol. 2016 Dec;12(4):341-349. doi: 10.1007/s13181-016-0588-y. Epub 2016 Oct 17.
6
A validated method for the quantification of mitragynine in sixteen commercially available Kratom (Mitragyna speciosa) products.一种用于定量测定十六种市售 kratom(帽柱木属)产品中帽柱木碱含量的经过验证的方法。
Forensic Sci Int. 2019 Jun;299:195-202. doi: 10.1016/j.forsciint.2019.04.009. Epub 2019 Apr 15.
7
Evaluation of the rewarding effects of mitragynine and 7-hydroxymitragynine in an intracranial self-stimulation procedure in male and female rats.评估米那布宗和 7-羟基米那布宗在雄性和雌性大鼠颅内自我刺激程序中的奖赏效应。
Drug Alcohol Depend. 2020 Oct 1;215:108235. doi: 10.1016/j.drugalcdep.2020.108235. Epub 2020 Aug 18.
8
Kratom (Mitragyna speciosa) Validation: Quantitative Analysis of Indole and Oxindole Alkaloids Reveals Chemotypes of Plants and Products.麻黄连轺赤小豆汤加减联合常规西药治疗小儿肾病综合征的效果
Planta Med. 2022 Aug;88(9-10):838-857. doi: 10.1055/a-1795-5876. Epub 2022 Apr 25.
9
Kratom (Mitragyna speciosa): worldwide issues.**译文**:**Kratom(**Mitragyna speciosa):全球问题。**
Curr Opin Psychiatry. 2020 Jul;33(4):312-318. doi: 10.1097/YCO.0000000000000621.
10
Chemistry and pharmacology of analgesic indole alkaloids from the rubiaceous plant, Mitragyna speciosa.茜草科植物帽柱木(Mitragyna speciosa)中镇痛吲哚生物碱的化学与药理学
Chem Pharm Bull (Tokyo). 2004 Aug;52(8):916-28. doi: 10.1248/cpb.52.916.

引用本文的文献

1
Exploring the Therapeutic Potential of Mitragynine and Corynoxeine: Kratom-Derived Indole and Oxindole Alkaloids for Pain Management.探索帽柱木碱和柯诺辛碱的治疗潜力:来自 kratom 的吲哚和氧化吲哚生物碱用于疼痛管理。
Pharmaceuticals (Basel). 2025 Feb 6;18(2):222. doi: 10.3390/ph18020222.
2
Trends in research on novel antidepressant treatments.新型抗抑郁治疗的研究趋势。
Front Pharmacol. 2025 Jan 27;16:1544795. doi: 10.3389/fphar.2025.1544795. eCollection 2025.
3
The Safety of Multiple-Dose Liquid Blend Containing Kava and Kratom in Healthy Adults.含卡瓦胡椒和 kratom 的多剂量混合液在健康成年人中的安全性。
Cureus. 2024 Dec 13;16(12):e75654. doi: 10.7759/cureus.75654. eCollection 2024 Dec.
4
Probing the Molecular Mechanisms of Kratom's Antipsychotic Effects through a Multi-modal Computational Approach.通过多模态计算方法探究 kratom 抗精神病作用的分子机制。
Curr Pharm Des. 2025;31(17):1370-1387. doi: 10.2174/0113816128335217241031033104.
5
An exploratory study of the safety profile and neurocognitive function after single doses of mitragynine in humans.单次给予人米托蒽醌后安全性概况及神经认知功能的探索性研究。 (注:原文中药物名称可能有误,正确的应该是米托坦“mitotane”,这里按照你提供的“mitragynine”翻译)
Psychopharmacology (Berl). 2025 Jun;242(6):1363-1376. doi: 10.1007/s00213-024-06734-2. Epub 2024 Dec 26.
6
Kratom: A Narrative Review of the Possible Clinical Uses and Dangers of This Opioid-Like Plant.kratom:一种类似阿片类植物的潜在临床用途与风险的叙述性综述
Cureus. 2024 Nov 5;16(11):e73058. doi: 10.7759/cureus.73058. eCollection 2024 Nov.
7
[Kratom-From natural remedy to addictive drug and back].[ kratom——从天然药物到成瘾性药物再回归]
Nervenarzt. 2024 Sep;95(9):824-829. doi: 10.1007/s00115-024-01721-6. Epub 2024 Jul 31.
8
A Critical Review of the Neuropharmacological Effects of Kratom: An Insight from the Functional Array of Identified Natural Compounds.**中文译文**: 基于鉴定天然化合物的功能多样性对东革阿里神经药理学作用的批判性评价
Molecules. 2023 Oct 31;28(21):7372. doi: 10.3390/molecules28217372.
9
Evaluating health information provided to kratom consumers by good manufacturing practice-qualified vendors.评估符合良好生产规范资质的供应商向卡痛消费者提供的健康信息。
Subst Abuse Treat Prev Policy. 2023 Apr 11;18(1):21. doi: 10.1186/s13011-023-00531-4.
10
Correlations of kratom (Mitragyna speciosa Korth.) use behavior and psychiatric conditions from a cross-sectional survey.横断面调查中,麻古(Mitragyna speciosa Korth.)使用行为与精神状况的相关性。
Exp Clin Psychopharmacol. 2023 Oct;31(5):963-977. doi: 10.1037/pha0000632. Epub 2023 Jan 12.

本文引用的文献

1
Investigation of the Adrenergic and Opioid Binding Affinities, Metabolic Stability, Plasma Protein Binding Properties, and Functional Effects of Selected Indole-Based Kratom Alkaloids.研究选定吲哚基咔哇生物碱的肾上腺素能和阿片样物质结合亲和力、代谢稳定性、血浆蛋白结合特性和功能效应。
J Med Chem. 2020 Jan 9;63(1):433-439. doi: 10.1021/acs.jmedchem.9b01465. Epub 2019 Dec 27.
2
Patterns and reasons for kratom (Mitragyna speciosa) use among current and former opioid poly-drug users.当前和既往阿片类药物多药使用者使用咔哇(Mitragyna speciosa)的模式和原因。
J Ethnopharmacol. 2020 Mar 1;249:112462. doi: 10.1016/j.jep.2019.112462. Epub 2019 Dec 7.
3
Pharmacologic and clinical assessment of kratom: An update.药物学和临床评估的咔特:更新。
Am J Health Syst Pharm. 2019 Nov 13;76(23):1915-1925. doi: 10.1093/ajhp/zxz221.
4
Self-reported Health Diagnoses and Demographic Correlates With Kratom Use: Results From an Online Survey.自我报告的健康诊断和人口统计学相关性与使用卡痛有关:来自在线调查的结果。
J Addict Med. 2020 May/Jun;14(3):244-252. doi: 10.1097/ADM.0000000000000570.
5
The Trouble With Kratom: Analytical and Interpretative Issues Involving Mitragynine.《东革阿里的问题:涉及到帽柱木碱的分析和解释问题》
J Anal Toxicol. 2019 Sep 10;43(8):615-629. doi: 10.1093/jat/bkz064.
6
Kratom as a substitute for opioids: Results from an online survey.**译文**:**作为阿片类药物替代品的** **Kratom** **:一项在线调查结果**。
Drug Alcohol Depend. 2019 Sep 1;202:24-32. doi: 10.1016/j.drugalcdep.2019.05.005. Epub 2019 Jun 29.
7
Increased Serum Levels of Cortisol and Inflammatory Cytokines in People With Depression.抑郁症患者血清皮质醇和炎性细胞因子水平升高。
J Nerv Ment Dis. 2019 Apr;207(4):271-276. doi: 10.1097/NMD.0000000000000957.
8
: Clinical, Toxicological Aspects and Analysis in Biological and Non-Biological Samples.临床、毒理学方面以及生物和非生物样本分析
Medicines (Basel). 2019 Mar 4;6(1):35. doi: 10.3390/medicines6010035.
9
The inhibitory effects of mitragynine on P-glycoprotein in vitro.东革阿里提取物对 P 糖蛋白的体外抑制作用。
Naunyn Schmiedebergs Arch Pharmacol. 2019 Apr;392(4):481-496. doi: 10.1007/s00210-018-01605-y. Epub 2019 Jan 2.
10
Comparative Pharmacokinetics of Mitragynine after Oral Administration of Mitragyna speciosa (Kratom) Leaf Extracts in Rats.大鼠口服帽柱木( kratom)叶提取物后帽柱木碱的比较药代动力学
Planta Med. 2019 Mar;85(4):340-346. doi: 10.1055/a-0770-3683. Epub 2018 Nov 16.